Student Pharmacist Non-Pharmacological Intervention on Type 2 Diabetes Management in Older Asian Adult Populations

NCT06861491 | Not Yet Recruiting

• 1 other identifier: 24-42131
• Study Type: interventional
• Target: 200
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study is being done to assess the impact of student pharmacist involvement on blood glucose control through non-pharmacological interventions in people of Asian and Asian descent over the age of 50 with type 2 diabetes. This study team is trying to advance the field of pharmacy and expand the roles of student pharmacists.

Conditions

Type 2 Diabetes Mellitus (T2DM)

Keywords

student pharmacist; non-pharmacological; diabetes; management; SPY-DM; glucose control; Asian; Older adult

Outcome Measures

Primary Outcomes (2)

• Blood glucose control

  This will assess the average blood glucose change over the course of the study.

  Up to 12 months

• A1C

  To assess effect of student pharmacist non-pharmacological intervention on A1C levels

  Up to 12 months

Secondary Outcomes (2)

• Utilization of Questionnaires to assess Comprehension of Diabetes Management

  Up to 12 months

• Utilization of Questionnaires to assess Participant Perceptions of Student Pharmacist Involvement on Chronic Disease Management

  Up to 12 months

Study Arms (2)

Non-pharmacological intervention and education by student pharmacists

EXPERIMENTAL

Student pharmacists will provide non-pharmacological recommendations to participants about lifestyle modifications, including exercise and diet, as well as provide information about current medications the participant is taking.

Behavioral: Non-pharmacological

Control

NO INTERVENTION

Student pharmacists will collect data on participants, but will not provide recommendations on non-pharmacological management. However, they will provide online resources on diabetes management if prompted.

Interventions

Non-pharmacological BEHAVIORAL

This intervention will be provided by student pharmacists. It will focus on lifestyle modifications, adherence, and education of disease state.

Also known as: Lifestyle, Diet, Exercise, Adherence

Non-pharmacological intervention and education by student pharmacists

Eligibility Criteria

• Age: 50 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults ≥ 50 years old
• Asian or Asian-descent
• Diagnosed with T2DM
• A1C \>7.0% (uncontrolled)
• Take blood glucose measurements as prescribed by their physician, or consistently (defined as missing no more than 1 reading from their regular routine).

You may not qualify if:

• Age \< 50 years old
• Not diagnosed with type 2 diabetes, or have diagnoses such as type 1 diabetes, gestational diabetes, or medication induced diabetes
• Patients that are on medications that affect glycemic control
• Corticosteroids
• First-generation antipsychotics (e.g. chlorpromazine, perphenazine, phenothiazines)
• Immunosuppressants (e.g. tacrolimus, cyclosporine)
• Experiencing acute disease states
• Recent surgery/hospitalized within the last 3 months
• Active infections
• Non-adherence to blood glucose monitoring (defined as missing \> 1 reading from their regular routine or not taking readings as prescribed by their doctor)
• Patients with late stage T2DM requiring insulin therapy
• Diagnosed with cancer, end-stage renal disease, end-stage liver disease
• Received any organ transplant

Sponsors & Collaborators

• University of California, San Francisco: lead

MeSH Terms

Conditions

Diabetes Mellitus, Type 2; Diabetes Mellitus

Interventions

Diet; Exercise

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Intervention Hierarchy (Ancestors)

Nutritional Physiological Phenomena; Diet, Food, and Nutrition; Physiological Phenomena; Motor Activity; Movement; Musculoskeletal Physiological Phenomena; Musculoskeletal and Neural Physiological Phenomena

Study Officials

• Crystal Zhou, PharmD

  University of California, San Francisco

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Crystal Zhou, PharmD

CONTACT

(415) 476-2354; crystal.zhou@ucsf.edu

Jerril Jacob, BS in Biochemistry

CONTACT

(510) 320-4977; jerril.jacob@ucsf.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 17, 2025
• First Posted: March 6, 2025
• Study Start: April 1, 2025
• Primary Completion: March 1, 2026
• Study Completion: April 1, 2026
• Last Updated: March 6, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will not share